Covid-19: Serum Institute to halt trial of Oxford vaccine after DCGI notice
By Administrator_India Capital Sands In a major turn of events, the Indian drug regulator on Wednesday issued a show cause notice to Serum Institute of India (SII), which had earlier said it would proceed with clinical trials of AZD1222, the vaccine candidate developed by the University of Oxford, despite a halt on the same by AstraZeneca in the UK. […]